GERN earnings call for the period ending March 31, 2020.
News & Analysis: Geron
The bio pharmaceutical announced fresh data on imetelstat that it will present at a key conference next month.
In this David versus Goliath battle, which biotech offers investors a greater return?
GERN earnings call for the period ending December 31, 2019.
Risk is high for a one-product biotech company.
Geron has a long road ahead. Is this speculative biotech stock worth the wait?
Formed in the early ‘90s, Geron and Incyte exemplify the long and often tumultuous road it takes to translate science into medicines.
GERN earnings call for the period ending September 30, 2019.
Which stock wins between these two biotechs?
These small-cap healthcare stocks are definitely worth checking out this month.